Biorce
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $6.5Mattributed |
|---|---|
| Latest round | seed, $5.4M, 2025-07-01attributed |
| Founded | 2023 |
| Headquarters | Madrid |
| Industry | bio |
| Stage | seed |
| Website | biorce.com |
AIKA AI assistant for clinical trials that supports protocol design, feasibility, regulatory readiness and patient recruitment using past-trial data. Sold to pharma sponsors, biotechs and CROs running clinical research. Reports halving protocol development time and cutting costly mid-study amendments, backed by a $52M Series A led by DST Global Partners.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-07-01 | seed | $5.4M | undisclosed |
Detected tech stack
Linkedin Insight Tag, Google Analytics, Google Tag Manager, Framer Sites, PHP, React 16.13.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $5.4M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $6.5M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | biorce.com, read 2026-05-02 |
| Description | self-reported | biorce.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.